Journal of Bioequivalence & Bioavailability

Journal of Bioequivalence & Bioavailability
Open Access

ISSN: 0975-0851

+44 7480022449

Kiran Vangara


Dr. Kiran Vangara obtained his bachelors and Masters in Pharmaceutical Sciences from Kakatiya University, India. Dr. Vangara graduated with a Ph.D. in Medical Sciences with Pharmaceutics specialization from reputed Texas A&M Health Science Center, College Station, TX. Currently, he is working as Formulations Scientist at Insys Therapeutics, Inc., USA, a specialty pharmaceutical company that develops innovative supportive care products. Dr. Vangara’s research experience encompasses both industry and academia. Dr. Vangara worked on National Institutes of Health (NIH) and Department of Defense (DOD) funded research projects on Novel Drug Delivery Systems for delivering therapeutics to cancer. Dr. Vangara’s research has been published in several peer-reviewed journals in the field of biomedical research. His current research at Insys Therapeutics is focused on improving the bioavailability of BCS class II & IV drug molecules using liquid formulations or lipid based delivery systems.

Research Interest

Solubility and Bioavailability Enhancement, Liquid or Softgel capsule Formulations, Novel Drug Delivery Systems, and Targeted Drug Delivery.